EXECUTIVE ENGAGEMENTS
POOL
22039
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1984
Interactions with Platform & by Email
PARTICIPANTS
441
Unique # Participated
VALIDATIONS
96
Responses Validated*
COMPANIES
71
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
153
PAGES
254
EDITION
15
PRICE
USD 5600
CODE
MCP-6222
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Clinical Trial Management Systems (CTMS) estimated at US$728.8 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 11.9% over the period 2020-2027. Enterprise CTMS, one of the segments analyzed in the report, is projected to record 12.8% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Site CTMS segment is readjusted to a revised 9.9% CAGR for the next 7-year period.
The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$215.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$279.7 Million by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 10% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.
SELECT PLAYERS
ArisGlobal LLC; BioClinica Inc.; Bio-Optronics Inc.; DSG Inc.; eResearch Technology Inc.; IBM Watson Health; Medidata Solutions; MedNet Solutions; Nextrials Inc.; Oracle Corp.; PAREXEL International Corp.; Trial By Fire Solutions LLC; Veeva Systems Inc.
SEGMENTS
» Type (Enterprise CTMS, Site CTMS) » Delivery Mode (Web-based (Hosted), Licensed Enterprise (On-Premise), Cloud-based (SaaS)) » End-Use (Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Clinical Trial Management Systems (CTMS) Gain Ground |
| Recent Market Activity |
| Benefits Offered by CTMS |
| Global Market Overview |
| Clinical Trial Management Systems Market to Post Explosive Growth |
| Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth |
| Key Players in the CTMS Market |
| Developed Countries Rule the Market |
| Pharmaceutical Firms and CROs to Drive Adoption Rate |
| Noteworthy Transformations in the Global Clinical Trial Sector |
| 2. FOCUS ON SELECT PLAYERS |
| ArisGlobal, LLC (USA) |
| BioClinica, Inc. (USA) |
| Bio-Optronics, Inc. (USA) |
| DSG, Inc. (USA) |
| eResearch Technology, Inc. (USA) |
| IBM Watson Health (USA) |
| MedNet Solutions (USA) |
| Medidata Solutions (USA) |
| Nextrials, Inc. (USA) |
| Oracle Corp. (USA) |
| PAREXEL International Corp. (USA) |
| Trial By Fire Solutions, LLC (USA) |
| Veeva Systems, Inc. (USA) |
| Winchester Business Systems (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Surging Global Population Offers Increased Growth Opportunities |
| Increased Spend on R&D - An Important Growth Driver |
| CROs - The Targeted Customers for CTMS |
| Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand |
| CROs Adept with New Technologies to See More Business in Future |
| Rise in Clinical Trial Complexities Propels CTMS Demand |
| Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand |
| Adoption of Digital Technologies Gains Pace |
| Clinical Trial Operators Demand Efficient Data Management Platforms |
| DLB System’s Solution with Data Management Tools |
| Systems Integration Becomes Imperative |
| Technological Innovations Drive Market Growth |
| MC10 Introduces BioStampRC System to Capture Clinical Trial Data |
| UF Health Cancer Center Unveils OnCore® Clinical Trials Management System |
| UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Enterprise CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Enterprise CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Enterprise CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Web-based (Hosted) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Web-based (Hosted) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Web-based (Hosted) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cloud-based (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cloud-based (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cloud-based (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical & Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical & Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 71 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com